161 related articles for article (PubMed ID: 2488545)
21. Multi-factorial modulation of IGD motogenic potential in MSF (migration stimulating factor).
Ellis IR; Jones SJ; Staunton D; Vakonakis I; Norman DG; Potts JR; Milner CM; Meenan NA; Raibaud S; Ohea G; Schor AM; Schor SL
Exp Cell Res; 2010 Sep; 316(15):2465-76. PubMed ID: 20403349
[TBL] [Abstract][Full Text] [Related]
22. The expression of migration stimulating factor, a potent oncofetal cytokine, is uniquely controlled by 3'-untranslated region-dependent nuclear sequestration of its precursor messenger RNA.
Kay RA; Ellis IR; Jones SJ; Perrier S; Florence MM; Schor AM; Schor SL
Cancer Res; 2005 Dec; 65(23):10742-9. PubMed ID: 16322219
[TBL] [Abstract][Full Text] [Related]
23. Purification and characterization of human lung fibroblast motility-stimulating factor for human soft tissue sarcoma cells: identification as an NH2-terminal fragment of human fibronectin.
Hu M; Pollock RE; Nicolson GL
Cancer Res; 1997 Aug; 57(16):3577-84. PubMed ID: 9270031
[TBL] [Abstract][Full Text] [Related]
24. Purification and biological characterization of epitaxin, a fibroblast-derived motility factor for epithelial cells.
Shimonaka M; Yamaguchi Y
J Biol Chem; 1994 May; 269(19):14284-9. PubMed ID: 8188713
[TBL] [Abstract][Full Text] [Related]
25. Fibroblasts from relatives of patients with hereditary breast cancer show fetal-like behaviour in vitro.
Haggie JA; Sellwood RA; Howell A; Birch JM; Schor SL
Lancet; 1987 Jun; 1(8548):1455-7. PubMed ID: 2885452
[TBL] [Abstract][Full Text] [Related]
26. Migration Stimulating Factor (MSF): Its Role in the Tumour Microenvironment.
Schor AM; Woolston AM; Kankova K; Harada K; Aljorani LE; Perrier S; Felts PA; Keatch RP; Schor SL
Adv Exp Med Biol; 2021; 1329():351-397. PubMed ID: 34664248
[TBL] [Abstract][Full Text] [Related]
27. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
Zarnegar R; Michalopoulos G
Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
[TBL] [Abstract][Full Text] [Related]
28. Purification and characterization of high molecular weight forms of inhibin from bovine follicular fluid.
Sugino K; Nakamura T; Takio K; Miyamoto K; Hasegawa Y; Igarashi M; Titani K; Sugino H
Endocrinology; 1992 Feb; 130(2):789-96. PubMed ID: 1733725
[TBL] [Abstract][Full Text] [Related]
29. Identification of a family of insulin-like growth factor II secreted by cultured rat epithelial-like cell line 18,54-SF: application of a monoclonal antibody.
Tanaka H; Asami O; Hayano T; Sasaki I; Yoshitake Y; Nishikawa K
Endocrinology; 1989 Feb; 124(2):870-7. PubMed ID: 2463906
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression.
Schor SL; Schor AM
Breast Cancer Res; 2001; 3(6):373-9. PubMed ID: 11737888
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast subpopulations as accelerators of tumor progression: the role of migration stimulating factor.
Schor SL
EXS; 1995; 74():273-96. PubMed ID: 8527899
[TBL] [Abstract][Full Text] [Related]
32. A 60-kDa phosphorylated protein from fetal human bone.
Suzuki M; Uchiyama A; Kushida K; Horiuchi K; Takahashi M; Inoue T
Biochem Biophys Res Commun; 1991 Jan; 174(2):439-45. PubMed ID: 1899565
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention.
Schor AM; Schor SL
Eye (Lond); 2010 Mar; 24(3):450-8. PubMed ID: 20019766
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of heparin-binding growth factors from porcine uterus.
Brigstock DR; Heap RB; Barker PJ; Brown KD
Biochem J; 1990 Feb; 266(1):273-82. PubMed ID: 2310377
[TBL] [Abstract][Full Text] [Related]
35. Purification of motility factor (GMF) from human malignant glioma cells and its biological significance in tumor invasion.
Ohnishi T; Arita N; Hayakawa T; Kawahara K; Kato K; Kakinuma A
Biochem Biophys Res Commun; 1993 Jun; 193(2):518-25. PubMed ID: 8390244
[TBL] [Abstract][Full Text] [Related]
36. The mast cell-committed progenitor. I. Description of a cell capable of IL-3-independent proliferation and differentiation without contact with fibroblasts.
Jarboe DL; Marshall JS; Randolph TR; Kukolja A; Huff TF
J Immunol; 1989 Apr; 142(7):2405-17. PubMed ID: 2784462
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterisation of soluble tumour haemolytic factor isolated from oncogene transformed fibroblasts.
Zucker S; Wieman J; Lysik RM; Imhof B; Farooqui AA
Br J Cancer; 1990 Jul; 62(1):28-32. PubMed ID: 2202421
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of TGF-beta1 on hyaluronan synthesis by fetal and adult skin fibroblasts: implications for cell migration and wound healing.
Ellis IR; Schor SL
Exp Cell Res; 1996 Nov; 228(2):326-33. PubMed ID: 8912726
[TBL] [Abstract][Full Text] [Related]
39. Characterization of human fibronectin glycopeptides from cystic fibrosis and control skin fibroblasts.
Stowell CP; Scanlin TF; Glick MC
Carbohydr Res; 1986 Aug; 151():279-92. PubMed ID: 3768895
[TBL] [Abstract][Full Text] [Related]
40. Purification of autocrine growth factor from conditioned medium of rat sarcoma (XC) cells.
Checiówna D; Klein A
Folia Histochem Cytobiol; 1996; 34(3-4):135-40. PubMed ID: 8967958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
